This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yamasa Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Chieri Takeuchi: Innovator in Muscle-Building and Mitochondria Activation
Introduction
Chieri Takeuchi is a notable inventor based in Choshi-shi, Japan. She has made significant contributions to the field of muscle-building and mitochondria activation through her innovative research. Although she currently holds no granted patents, her work is focused on developing agents that promote muscle health and enhance mitochondrial function.
Latest Patent Applications
Chieri Takeuchi's latest patent applications include two significant inventions. The first is titled "PGC-1alpha EXPRESSION PROMOTING AGENT, MUSCLE-BUILDING AGENT AND MITOCHONDRIA ACTIVATING AGENT." This invention relates to a PGC-1α expression promoting agent, a muscle-building agent, or a mitochondria activating agent, which comprises at least one pyrimidine nucleotide or a precursor thereof as an active ingredient. The second application is for a "MUSCULAR ATROPHY INHIBITOR AND METHOD FOR INHIBITING MUSCULAR ATROPHY." This invention is a muscular atrophy inhibitor that also comprises at least one pyrimidine nucleotide or a precursor thereof as an active ingredient, along with a method for inhibiting muscular atrophy through administration of the same.
Conclusion
Chieri Takeuchi is an innovative inventor whose work focuses on enhancing muscle health and mitochondrial function. Her latest patent applications reflect her commitment to advancing research in these important areas.